Evidence map›Paper›PMID 38981928›Full record

ArticleJournal of molecular neuroscience : MN2024

Investigation of the Circular Transcriptome in Alzheimer's Disease Brain.

Yulan Gao, Si-Mei Xu, Yuning Cheng, Konii Takenaka, Grace Lindner, Michael Janitz

Abstract read
In one paragraph

Article in Journal of molecular neuroscience : MN, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Cells · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yulan GaoSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Si-Mei XuSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Yuning ChengSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Konii TakenakaSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Grace LindnerSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Michael JanitzSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia. m.janitz@unsw.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a subclass of non-coding RNAs which have demonstrated potential as biomarkers for Alzheimer's disease (AD). In this study, we conducted a comprehensive exploration of the circRNA transcriptome within AD brain tissues. Specifically, we assessed circRNA expression patterns in the dorsolateral prefrontal cortex collected from nine AD-afflicted individuals and eight healthy controls. Utilising two circRNA detection tools, CIRI2 and CIRCexplorer2, we detected thousands of circRNAs and performed a differential expression analysis. CircRNAs which exhibited statistically significantly differential expression were identified as AD-specific differentially expressed circRNAs. Notably, our investigation revealed 120 circRNAs with significant upregulation and 1325 circRNAs displaying significant downregulation in AD brains when compared to healthy brain tissue. Additionally, we explored the expression profiles of the linear RNA counterparts corresponding to differentially expressed circRNAs in AD-afflicted brains and discovered that the linear RNA counterparts exhibited no significant changes in the levels of expression. We used CRAFT tool to predict that circUBE4B had potential to target miRNA named as hsa-miR-325-5p, ultimately regulated CD44 gene. This study provides a comprehensive overview of differentially expressed circRNAs in the context of AD brains, underscoring their potential as molecular biomarkers for AD. These findings significantly enhance our comprehension of AD's underlying pathophysiological mechanisms, offering promising avenues for future diagnostic and therapeutic developments.

Indexed as

Alzheimer DiseaseMicroRNAsRNA, CircularTranscriptomeAgedBiomarkersBrainFemaleHumansHyaluronan ReceptorsMaleBiomarkersCD44 protein, humanHyaluronan ReceptorsMicroRNAsRNA, CircularAlzheimer’s diseasecircRNAsHuman brainRNA sequencingTranscriptome

Identifiers

PMID38981928
PMCPMC11233389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.